Leveraging Transparency Data to Enhance Commercial Targeting:
A Case Study in Chronic Obstructive Pulmonary Disease
Published January 2017 • 6 Pages
By augmenting traditional sales force targeting approaches with emerging transparency data, drug and device makers can gain a more comprehensive understanding of promotionally accessible prescribers and increase overall share of voice in high value accounts:
- Insight into market-level promotional activity and competitive intensity
- Perspective on physician-level access and receptiveness to personal promotion
- Identification of brand coverage gaps and opportunities to increase share of voice
